Probiotics for gut health and blood lipid regulation in adults
Effect of Probiotics on Regulating Gut Health and Blood Lipid in Overweight and Obese Adults
This study tests whether taking Nutrarex Probiotic Capsules can improve gut health and help manage blood lipid levels in adults.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 20 Years to 65 Years |
| Sex | All |
| Sponsor | Chung Shan Medical University Academic / other |
| Locations | 1 site (Taichung, South) |
| Trial ID | NCT06554314 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of Nutrarex Probiotic Capsules in improving gut health and regulating blood lipid levels in adults. Participants are required to maintain their usual lifestyle for two weeks before the trial, ensuring a stable body weight. The trial involves 50 subjects who are randomly assigned to either a probiotic group or a placebo group, taking one capsule daily for four weeks. Various health metrics, including blood tests, body composition, and dietary questionnaires, are assessed before and after the intervention.
Who should consider this trial
Good fit: Ideal candidates are adults aged 20-65 with a body mass index between 25-27 kg/m2 or body fat exceeding 25% for men and 30% for women.
Not a fit: Patients with cancer, chronic heart disease, or those currently using probiotics may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a new dietary approach to managing obesity and improving gut health.
How similar studies have performed: Previous studies have shown promising results with probiotics in managing gut health and metabolic conditions, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * male or female participants * aged 20-65 years old * body mass index in 25-27 kg/m2 or body fat \> 25% for men and \> 30% for women Exclusion Criteria: * cancer, chronic heart disease, use drugs which pharmacological effects may affect immunity having systemic infections * using probiotics.
Where this trial is running
Taichung, South
- Chung Shan Medical University — Taichung, South, Taiwan (Recruiting)
Study contacts
- Principal investigator: Yin-Chin Liu, MS student — Chung Shan Medical University
- Study coordinator: Chin-Lin Hsu, Professor
- Email: clhsu@csmu.edu.tw
- Phone: 04-24730022
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.